Private Equity Interest in Healthcare Commercialization
Private equity interest in healthcare commercialization has accelerated as investors seek scalable opportunities across biotechnology services, clinical infrastructure, and commercialization platforms. As drug development pipelines grow and new therapies reach regulatory milestones, financial sponsors increasingly view commercialization support services as a strategic entry point into the healthcare ecosystem. Unlike early stage biotechnology investment, which carries … Read more